$0.4445
-0.0011-0.25%
Last update: Nov 11, 9:27 AM
Aprea Therapeutics Inc
APRENASDAQ
Aprea Therapeutics fell 66.3% from $1.32 to $0.44, behind the S&P 500's +9.8%. Its worst day was Jan 29 (−22.8%), and its low came Nov 11 at $0.44.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.47 missed the $-0.10 estimate on $1,848.00 revenue.
−4.5% · S&P 500 +0.1%
Aprea Therapeutics shares fell 18.3%, while the S&P 500 rose 0.1%.
Story events cover the past 12 months · Times ET
−18.3% · S&P 500 +0.1%
Aprea Therapeutics shares rose 34.9%, while the S&P 500 fell 0.3%.
+34.9%, the year's best day, on 110M shares, the year's heaviest volume · S&P 500 −0.3%
Aprea Therapeutics shares rose 21.3%, while the S&P 500 rose 0.5%.
+21.3% · S&P 500 +0.5%
EPS of $-0.32 beat the $-0.37 estimate on $3,337.00 revenue.
+2.7% · S&P 500 +1.0%
Aprea Therapeutics shares rose 24.9%, while the S&P 500 fell 0.1%.
+24.9% · S&P 500 −0.1%
EPS of $-0.22 beat the $-0.23 estimate on $0.00 revenue.
−2.2% · S&P 500 +0.6%
EPS of $-0.07 beat the $-0.22 estimate on $0.00 revenue (est. $203,200.00).
+3.2% · S&P 500 +0.3%
Aprea Therapeutics shares rose 25.8%, while the S&P 500 fell 0.3%.
+25.8% · S&P 500 −0.3%
EPS of $-0.09 missed the $-0.08 estimate on $0.00 revenue (est. $124,000.00).
−1.9% · S&P 500 +1.7%
Where it ended: a close of $0.44 on Nov 11, 2026.
Nothing in the past 12 months.
All APRE dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for APRE and SPY from Benzinga historical bars. Not investment advice.
